6533b7d0fe1ef96bd125ad43
RESEARCH PRODUCT
Cisplatin/5-fluorouracil +/- panitumumab for patients with non-resectable, advanced or metastatic esophageal squamous cell cancer : A randomized phase III AIO/EORTC trial with an extensive biomarker program
Richard GreilKersten BorchertLothar MuellerE. Van CutsemJohannes MeilerMarkus MoehlerBaruch BrennerRalph KellerF. Longo MuñozThomas J. EttrichPeter C. Thuss-patienceA. KaratasJ. HeckerM. AlsinaR.d. HofheinzJulian Larcher-sennS.-e. Al-batranManfred P. LutzArndt VogelSylvie LorenzenAnnett Maderersubject
0301 basic medicineCisplatinOncologymedicine.medical_specialtySquamous cell cancerbusiness.industryMedizinHematology03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyFluorouracil030220 oncology & carcinogenesisInternal medicinemedicinePanitumumabBiomarker (medicine)businessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2018-06-01 |